BEDFORD, MA / ACCESSWIRE / JANUARY 13, 2019 / FORMULATRIX has announced that their digital PCR assets, including the CONSTELLATION ® series of instruments, is being acquired by QIAGEN N.V. for up to ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results